Renalytix (LSE:RENX) Shares Buyback Ratio % : -27.87 (As of May. 25, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Renalytix Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Renalytix's current shares buyback ratio was -27.87%.

Renalytix Shares Buyback Ratio % Historical Data

The historical data trend for Renalytix's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Shares Buyback Ratio % Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-10.41

-21.51

-3.55

-25.44

Renalytix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-25.22	-	-1.32	-5.17	-20.00

Renalytix Shares Buyback Ratio % Calculation

Renalytix's Shares Buyback Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2022 )	-	Shares Outstanding (EOP) (A: Jun. 2023 ))	/	Shares Outstanding (EOP) (A: Jun. 2022 )
	=	(74.7604	-	93.7815)	/	74.7604
	=	-25.44%

Renalytix's Shares Buyback Ratio for the quarter that ended in Mar. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Mar. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(99.9302	-	119.916)	/	99.9302
	=	-20.00%

Renalytix Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Renalytix's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix (LSE:RENX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

RNLX:USA RTNXF:USA 2O9:Germany

Address

5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (LSE:RENX) Headlines

From GuruFocus

Investing in Information

By Vanina Egea Vanina Egea • 03-06-2014

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

By PRNewswire PRNewswire • 03-27-2018

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe • 08-29-2013

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex • 12-14-2012